-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Rocket Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2018 to 2023.
- Rocket Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $1.9M, a 58.3% increase year-over-year.
- Rocket Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the twelve months ending September 30, 2024 was $6.8M.
- Rocket Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $4.9M, a 25.6% increase from 2022.
- Rocket Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $3.9M, a 21.9% increase from 2021.
- Rocket Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $3.2M, a 179% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)